SOLV:NYE-Solventum Corp. (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 66.2

Change

0.00 (0.00)%

Market Cap

USD 11.45B

Volume

1.87M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-06 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+8.52 (+4.24%)

USD 65.91B
ALC Alcon AG

+7.11 (+8.58%)

USD 46.01B
RMD ResMed Inc

+11.90 (+5.82%)

USD 34.14B
BAX Baxter International Inc

+2.78 (+9.94%)

USD 18.71B
AVTR Avantor Inc

+1.61 (+11.27%)

USD 11.92B
ATR AptarGroup Inc

+10.09 (+7.55%)

USD 10.16B
TFX Teleflex Incorporated

+8.02 (+6.31%)

USD 6.39B
STVN Stevanato Group SpA

+2.07 (+11.15%)

USD 5.88B
BLCO Bausch + Lomb Corp

+1.53 (+13.91%)

USD 4.29B
WRBY Warby Parker Inc

+2.26 (+15.84%)

USD 2.55B

ETFs Containing SOLV

HLTH:AU VanEck Global Healthcare .. 2.45 % 0.00 %

-0.35 (9.95%)

USD 0.06B
INVN The Alger ETF Trust 2.45 % 0.00 %

+1.54 (+9.95%)

N/A
CSD Invesco S&P Spin-Off ETF 0.00 % 1.16 %

+7.05 (+9.95%)

N/A
CSD Invesco S&P Spin-Off ETF 0.00 % 0.61 %

+7.05 (+9.95%)

N/A
XHE SPDR® S&P Health Care Eq.. 0.00 % 0.35 %

+5.37 (+9.95%)

USD 0.18B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.21% 100% F 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.21% 95% A 75% C
Trailing 12 Months  
Capital Gain -5.51% 74% C 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.51% 68% D+ 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.09% 50% F 34% F
Dividend Return 0.09% 50% F 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1.32% 100% F 99% N/A
Risk Adjusted Return 6.81% 70% C- 26% F
Market Capitalization 11.45B 67% D+ 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.